Trials Update Connie Shiridzinomwa Urology Research Nurse.

Slides:



Advertisements
Similar presentations
FRISC II: Fragmin and fast Revascularization during InStability in Coronary artery disease - LONG-TERM HEPARIN - Purpose To assess efficacy of long-term.
Advertisements

PROSTATE CANCER Dr Samad Zare Assistant Proffesor of Urology Shaheed Sadoughi University of Medical Sciences.
National Prostate Cancer Audit Heather Payne, NPCA Oncological Clinical Lead Consultant Clinical Oncologist, UCL.
The PRIAS Study In Australia One Institution’s Experience Introduction PRIAS (Prostate cancer Research International: Active Surveillance – NTR1718) is.
Prevention Strategies Rajesh G. Laungani MD Director, Robotic Urology Chairman, Prostate Cancer Center Saint Joseph’s Hospital, Atlanta.
Wrexham Maelor Lung Clinical Trials Overview February 2008.
R&D 2013 RESEARCH & DEVELOPMENT UNIT WEST SUFFOLK HOSPITAL.
Survivorship Update January 2015 The Royal Wolverhampton NHS Trust James Owen Senior Cancer Services Manager.
Delivering clinical research to make patients, and the NHS, better Breast Cancer Research Report Site Specific Group Meeting Tuesday 13 th January 2015.
Surrogate End point for Prostate Cancer- Specific Mortality After RP or EBRT A D’Amico J Nat Ca Inst 95,
Delivering clinical research to make patients, and the NHS, better Haematological Cancer Research Report Site Specific Group Meeting Tuesday 14 th October.
Cancer Centers In Clinical Trials Sandrine Marreaud Head of Medical Department.
Protocols for Advanced Prostate Cancer and/or Local Failure After Radical Prostatectomy Isaac Powell, MD.
24/09/041 SIR and the Management of Cancer Trial Data Kate Motohashi Gray Cancer Institute, Northwood, UK.
Delivering clinical research to make patients, and the NHS, better Upper GI SSG March 2015 Research Wendy Cook, Research Delivery Manager dd/mm/yyyy.
Hysterectomy after Chemoradiotherapy for Stage Ib2 and IIb Cervical Cancer Vivek Nama UHBT.
Facilitating tissue collection for translational research Jane Rogan Business Manager.
New developments in Prostate Cancer Dr Jo Bowen Consultant Oncologist Worcestershire Royal Hospital.
Life after Prostate Cancer and its treatment Mr Sanjeev Pathak Consultant Urological Surgeon and Cancer Lead Doncaster and Bassetlaw NHS Trust 12 th March.
Prostate cancer update Suresh GANTA Consultant urological surgeon Manor Hospital.
NIHR Southampton Biomedical Research Centre The Southampton Biomedical Research Centre is funded by the National Institute for Health Research (NIHR) and.
Manit Arya Consultant Urological Surgeon UCLH and PAH Transforming the Pathway in Prostate Cancer.
SWAG SSG Skin Meeting Thursday 22nd September 2016 Maxine Taylor
Per-Anders Abrahamsson Department of Urology Malmö University Hospital
DESIGN AND APPROVAL OF A RANDOMIZED, DOUBLE BLIND, PLACEBO CONTROLLED TRIAL OF THE ACE INHIBITOR CAPTOPRIL IN COMBINATION WITH IBUPROFEN IN THE TREATMENT.
SWAG SSG Sarcoma Meeting
Genomic Medicine Centre Overview
Colorectal Cancer Research Report SWAG Site Specific Group
SWAG SSG Skin Cancer Meeting
New developments in Prostate Cancer
Stage I Non Small Cell Lung Cancer (NSCLC): single centre comparison of outcome by treatment with surgery, conventional radiotherapy and stereotactic ablative.
Skin Cancer Research Report SWAG SSG Maxine Taylor Senior Research Delivery Manager 17/05/2016.
Breast Cancer Research Report SWAG Site Specific Group
SWAG SSG Breast Cancer Meeting
#96 Roles Of Urodynamics In the Assessment of Post Radical
S1207: Phase III randomized, placebo-controlled trial adding 1 year of everolimus to adjuvant endocrine therapy for patients with high-risk, HR+, HER2-
Clinical research in Southampton is a partnership between University Hospital Southampton (UHS) NHS Foundation Trust and the University of Southampton.
The NIHR Southampton Clinical Research Facility was established by the Wellcome Trust and the Department of Health in The NIHR Southampton Clinical.
SWAG SSG Skin Cancer Meeting Tuesday 22nd May Research Report
Balancing the practical implications of adaptive designs with the statistical benefits Mahesh Parmar MRC Clinical Trials Unit at UCL.
SWAG SSG Haematology and Lymphoma Meeting
SWAG SSG Sarcoma Cancer Meeting
Apollo Gleneagles Hospitals,
Volume 49, Issue 5, Pages (May 2006)
Genomic Medicine Centre Overview
Title The NIHR Southampton Clinical Research Facility was established by the Wellcome Trust and the Department of Health in The NIHR Southampton.
Title Clinical research in Southampton is a partnership between University Hospital Southampton (UHS) NHS Foundation Trust and the University of Southampton.
Genomic Medicine Centre Overview
Intermittent Hormone Therapy: What Is Its Place in Clinical Practice?
Reviewer: Dr. Sunil Verma Date posted: December 12th, 2011
SWAG SSG Gynaecological Cancers Meeting
SWAG SSG Skin Cancer Meeting
SWAG SSG Head and Neck Cancer Meeting
An Introduction to the NIHR programmes
Challenges of Recruitment in Haematology Trials
Title Clinical research in Southampton is a partnership between University Hospital Southampton (UHS) NHS Foundation Trust and the University of Southampton.
Clinical research in Southampton is a partnership between University Hospital Southampton (UHS) NHS Foundation Trust and the University of Southampton.
Prostate Cancer Update
Genomic Medicine Centre Overview
Clinical research in Southampton is a partnership between University Hospital Southampton (UHS) NHS Foundation Trust and the University of Southampton.
Cancer specialty specific objectives
SWAG Network Breast Cancer Site Specific Group
Oncoforum Urology: Prostate Cancer 2008 at a Glance
Title Southampton Clinical Research Facility Southampton Biomedical Research Centre Clinical research in Southampton is a partnership between University.
Clinical research in Southampton is a partnership between University Hospital Southampton NHS Foundation Trust and the University of Southampton, combining.
The NIHR Southampton Clinical Research Facility was established by the Wellcome Trust and the Department of Health in The NIHR Southampton Clinical.
CORE: A randomised trial of COnventional care versus Radioablation (stereotactic body radiotherapy (SBRT)) in Extracranial oligometastases (CRUK/14/038)
A case of localized Prostate Cancer Marije Hamaker.
Living With & Beyond Cancer (Personalised Care): SWAG Colorectal CAG Update 5th June 2019 Catherine Neck, Macmillan Cancer Rehabilitation/ LWBC Lead On.
Uncovering the Right Sequence
Presentation transcript:

Trials Update Connie Shiridzinomwa Urology Research Nurse

Recruiting trials Add-Asprin IROC Pre-Empt PRIM

Recruiting Trials Add-aspirin A phase III, double-blind, placebo-controlled, randomised trial assessing the effects of aspirin on disease recurrence and survival after primary therapy in common non-metastatic solid tumours. Recruiting areas, gastro, prostate and colorectal Target 30 end of recruitment January 2021 Recruited 24 Recruitment challenges: Uptake decrease following media

Recruiting trials IROC A phase III multicentre randomised controlled trial to compare the efficacy of Robotically Assisted Radical Cystectomy (RARC) and intracorporeal urinary diversion with Open Radical Cystectomy (ORC) in patients with bladder cancer Trust target 15 end of recruitment Nov 2018 Recruited 12 Challenges: Large catchment area network patients not prepared to come back for follow-up visits.

Recruiting Trials Pre-EMPT: The Prostate cancer – Exercise and Metformin Trial (Pre-EMpT) is organised by the National Institute for Health Biomedical Research Centre (Nutrition), which is funded by the National Institute for Health Research and is a partnership between the University Hospitals Bristol NHS Foundation Trust and the University of Bristol. Target 183, end date March 2020 Recruited 6, all in surgery Recruitment challenges: Slow up take, people already on Metformin, difficult pathway for radiotherapy and AS

Recruiting trials PRIM: Prostate Health Index (PHI)- to Refine prostate Imaging by MRI (PRIM): Target 100, end of recruitment August 2019 Recruited from 28 No challenges at present

Trials in follow-up POUT (close date Dec 2021) Boxit (close date Dec 2018) Radicals (close date 2031) Source (follow-up until progression) MASTER (closing date Dec 2019)

Studies in set-up JANSSEN: Randomized, Double-blind, Placebo-controlled, Phase 3 Study of Apalutamide in Subjects with High-risk, Localized or Locally Advanced Prostate Cancer Who are Candidates for Radical Prostatectomy HAARP: (Newcastle) Home Assessment of urinary voiding and storage function before and After Radical Prostatectomy for prostate cancer: setting patient expectations (The HAARP study) Neurosafe : (UCL)   A single blinded, multi‐centre, feasibility study to evaluate the ability to randomise men with prostate cancer into a trial comparing NeuroSAFE Robotic assisted radical prostatectomy (RALP) to standard Robotic assisted radical prostatectomy(RALP).

Studies in set up CamProbe: ( Cambridge)Developing a safer and simple device for local anaesthetic transperineal prostate biopsies Gap 4  Interval: (Movember)difficulties in setting this study up include delivery of the exercise intervention, work is ongoing to try to resolve this.

Thank you for your patience.